On-demand education
Robotic radical prostatectomy
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
Prof. Mottet and Prof. Cornford discuss active surveillance for prostate cancer
Dr. Constance Thibault talks about triplet therapy in mHSPC
PARP Inhibitor in Prostate Cancer. Part III
WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?
Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 2
Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 1
Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)
PARP inhibitors in prostate cancer. Part 2
Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments
Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
Artificial intelligence: The role for research and patient treatment
UROwebinar: PARP inhibitors in prostate cancer. Part 1
Identification and management of patients with nmCRPC